Low vision and blind aids market seen reaching $5.46 billion by 2030
The global market for low vision and blind aids products is forecast to grow from $3.32 billion in 2025 to $3.68 billion in 2026, driven by rising vision loss, policy support and new assistive technologies. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region through 2030.
Why it matters: - The low vision and blind aids products market is expanding as more people live with vision loss and demand more accessible tools for daily life. - Growth in assistive devices can improve mobility, communication and independence for people with partial or total vision loss. - The market's expected rise to $5.46 billion by 2030 points to sustained demand across healthcare, education and consumer technology.
What happened: - The Business Research Company said the low vision and blind aids products market is forecast to rise from $3.32 billion in 2025 to $3.68 billion in 2026. - The company projected a 10.8% CAGR for 2026. - The market is expected to reach $5.46 billion by 2030, at a 10.4% CAGR. - North America held the largest regional share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report was released Aug. 14, 2026, from London. - Download a free sample of the market report. - View the full market report.
The details: - Low vision and blind aids are specialized assistive devices for people with partial or total vision loss. - The products combine optical, tactile and auditory technologies. - The tools are designed to improve visual function, mobility, communication and daily activities. - The market's recent growth has been supported by more people with visual impairments, wider awareness of low vision aids, government programs for disabled communities, advances in optical devices and early adoption by educational organizations. - Rising eye disease prevalence is a major growth driver. - Increasing screen time adds to eye strain and can accelerate vision issues. - CDC data released in May 2024 showed more than 90 million Americans age 40 and older face vision problems. - The CDC projected U.S. vision impairment and blindness cases will rise 150% by 2050. - The CDC expects diabetic retinopathy cases to increase 72%, cataracts 87%, and glaucoma and macular degeneration to double. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report also includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Between the lines: - The forecast suggests the market is shifting from basic accessibility tools toward smarter, more connected products. - Artificial intelligence, wearable tech, portable electronic aids and mobile integration are emerging as the next growth engines. - Demand tied to inclusive education and employment points to a broader shift from medical support alone toward participation in school and work. - Asia-Pacific's faster growth likely reflects expanding access, adoption and market development rather than current market leadership.
What's next: - The market is expected to keep growing as AI-enabled vision tools, voice-controlled assistive devices and smart navigation aids move into broader use. - More affordable low-vision solutions and stronger online sales channels are likely to widen access. - Inclusive education and employment initiatives may support further adoption through 2030. - The Business Research Company invited readers to speak with its experts at the contacts listed in the release.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Healthcare
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.